Abstract
Donor leukocyte infusion (DLI) was carried out on a 12-year-old girl with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) who received allogeneic bone marrow transplantation from an HLA-identical sibling. This is the first report of DLI use before the onset of hematological relapse monitored by the results of RT-PCR. This patient has been in CR for 11 months after BMT, suggesting this alternative treatment is promising for Ph+ ALL with positive reverse transcriptase-polymerase chain reaction (RT-PCR) following BMT.
| Original language | English |
|---|---|
| Pages (from-to) | 393-394 |
| Number of pages | 2 |
| Journal | Bone Marrow Transplantation |
| Volume | 19 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 02-02-1997 |
| Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Hematology
- Transplantation
Fingerprint Dive into the research topics of 'Successful prevention of hematological relapse for a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic bone marrow transplantation by donor leukocyte infusion'. Together they form a unique fingerprint.
Cite this
Yazaki, M., Andoh, M., Ito, T., Ohno, T., & Wada, Y. (1997). Successful prevention of hematological relapse for a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic bone marrow transplantation by donor leukocyte infusion. Bone Marrow Transplantation, 19(4), 393-394. https://doi.org/10.1038/sj.bmt.1700663